缺血性卒中急性期西医治疗方法及优势研究进展

Research Progress on Western Medical Treatment Methods and Their Advantages in the Acute Phase of Ischemic Stroke

摘要: 缺血性卒中作为全球致残率和病死率最高的神经系统疾病之一，急性期治疗始终是医学研究热点。中医通过辨证论治、中药及针灸等手段在整体调理与康复中具优势，但急性期快速逆转缺血损伤存在局限。而西医治疗的进展显著：静脉溶栓方面，替奈普酶凭借更高纤维蛋白特异性替代阿替普酶，影像筛选技术扩展其至时间不明患者；动脉取栓联合神经保护剂将治疗窗延至24小时，EVT联合方案显著提升90天功能独立率。本文通过整合近些年高质量临床研究数据，深入探讨西医治疗在改善患者神经功能、降低致残率和病死率等方面的作用机制与临床价值，为临床实践提供参考依据。

Abstract: Ischemic stroke, as one of the neurological diseases with the highest disability and mortality rates worldwide, has always been a hot topic in medical research for the treatment of its acute phase. This article systematically reviews the research progress of Western medicine treatment methods for acute ischemic stroke in recent years, including intravenous thrombolysis, arterial thrombectomy, antiplatelet therapy, anticoagulant therapy, neuroprotective agent therapy, etc. The focus is on analyzing the technological breakthroughs and clinical advantages of various therapies. This article provides a comprehensive review of high-quality clinical research data from recent years, delving into the mechanisms and clinical value of Western medicine treatment in improving patients’ neurological function, reducing disability and mortality rates. It aims to offer a reference for clinical practice.